 Jounce Therapeutics, Inc. NASDAQ:JNCE Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Eric Laub - VP, IR Richard Murray - President, CEO Director Elizabeth Trehu - Chief Medical Officer Kimberlee Drapkin - Chief Financial Officer Treasurer Dmitri Wiederschain - Chief Scientific Officer Conference Call Participants Boris Peaker - Cowen and Company Steven Seedhouse - Raymond James Associates Edward Tenthoff - Piper Sandler Co. Cory Kasimov - JPMorgan Chase Co. David Dai - SMBC Arthur He - H.C. Wainwright Co. Nicholas Abbott - Wells Fargo Securities Operator Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2022 Earnings Conference Call. 